Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted ...
Artificial intelligence is transforming food innovation by accelerating ingredient discovery, optimizing formulations, and enabling personalized nutrition strategies to improve public health outcomes.
CPRX at $24.50 offers 7.5% FCF yield with elite metrics, but patent cliff risk and insider selling suggest fair value, not deep value. Upside ~19.5%.
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results